Under construction – not a live service
Sign in

What researchers published on Macular degeneration

1,896 papers, newest first.

Showing 20 of 1,896

  • Not labelled yetReal-World Twelve-Month Outcomes of Switching from Aflibercept to Faricimab in Chinese Neovascular Age-Related Macular Degeneration with Inadequate Aflibercept Response.Drug design, development and therapy
  • Not labelled yetComparison of Aflibercept and Brolucizumab in Treatment-Naïve Neovascular Age-related Macular Degeneration with Thick Pigment Epithelial Detachments.Korean journal of ophthalmology : KJO
  • ReviewAn update on pharmacotherapies and emerging therapeutic approaches for geographic atrophy.Expert opinion on pharmacotherapy
  • PreprintEngineered regulatory states resolve context-dependent genetics in macular degeneration.bioRxiv : the preprint server for biology
  • ReviewStatin Use and Age-related Macular Degeneration: A Systematic Review and Meta-Analysis of Disease Outcomes.American journal of ophthalmology
  • Not labelled yetPlasma proteome-driven discovery of therapeutic targets for age-related macular degeneration: a multi-omics mendelian randomization framework.Molecular genetics and genomics : MGG
  • ReviewPegcetacoplan for geographic atrophy: Bridging the "clinical relevance gap" through precision medicine.Survey of ophthalmology
  • Not labelled yetFas Ligand enhances vessel maturation and inhibits vascular leakage associated with age-related macular degeneration.Frontiers in immunology
  • Not labelled yetCentral-field stimulus thresholds in age-related macular degeneration: Associations with visual function and retinal structure.Advances in ophthalmology practice and research
  • Not labelled yetLongitudinal Systemic C-Reactive Protein and Risk of Progression to Advanced Age-Related Macular Degeneration.Journal of vitreoretinal diseases
  • Not labelled yetEarly macular dryness after four loading injections of faricimab was associated with reduced two-year treatment burden in treatment-naïve neovascular age-related macular degeneration.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
  • Not labelled yetOccurrence, progression and risk factors of macular atrophy in neovascular age-related macular degeneration according to neovascularization subtypes.Acta ophthalmologica
  • ReviewFluid fluctuation and visual outcomes in neovascular age-related macular degeneration: A systematic review and meta-analysis.Survey of ophthalmology
  • Trial resultFirst-in-Human Regulatory T Cell-Derived Exosomes Plus Ranibizumab for Refractory nAMD.Journal of extracellular vesicles
  • Not labelled yetRisk of age-related macular degeneration: population-attributable fractions in 600 000 individuals without genetic information or baseline ocular phenotypes from two contemporary population-based studies.BMJ open ophthalmology
  • Not labelled yetCombined Versus Monotherapy Anti-Complement and Anti-Vascular Endothelial Growth Factor Intravitreal Injections for Age-Related Macular Degeneration: Safety Outcomes in the Real World.Ophthalmology. Retina
  • Not labelled yetThree-Year Real-World Outcomes of Switching to Brolucizumab for Refractory Neovascular Age-Related Macular Degeneration.Korean journal of ophthalmology : KJO
  • Not labelled yetMetabolomic Signatures of Healthy Dietary Patterns Associated With Lower Risk of Age-Related Macular Degeneration.Investigative ophthalmology & visual science
  • Not labelled yetLipidomic and transcriptomic remodeling underlies early retinal pathogenesis in dry age-related macular degeneration.Cell death & disease
  • Not labelled yetA tetravalent bispecific protein enables targeted degradation of VCAM-1 and VEGFR for treatment of choroidal neovascularization.Proceedings of the National Academy of Sciences of the United States of America